Esense-Lab Ltd (ese) Logo

Esense-Lab Ltd (ESE)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

ESE Chart

Snapshot

ESE's Principal Activity is the technology and research development, specialising in the commercialisation of the phytochemical profiling of plants.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -4.34%
vs ASX 200 (1yr) -22.66%

Size

Market Capitalisation
ASX Rank 2,098 of 2,319
Sector Rank 185 of 199

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies ALT / CAU / 1ST
EPS -$0.016
DPS $0.00
NTA per share $0.00

Broker Consensus

ESE is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

Esense-Lab Ltd (ESE) is an Israel-based technology and research development company specialising in the commercialisation of the phytochemical profiling of plants. The Company combines genetics, mRNA, protein expression and phytochemical profiles to generate a comprehensive model of rare or high value plants. eSense-Lab can then use this model to 'reverse engineer' a terpene profile, which is a naturally occurring formulation of different individual terpenes.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office
Website -
Registry Link Market Services
Auditor BDO
Date Listed 14 Feb 2017

Upcoming Calendar (Forecasted)

Date Event
28/02/2022 Report (Prelim)
25/03/2022 Report (Annual)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Yoav Elishoov Chief Executive Officer Dec 2020
Mr Winton William Willesee Joint Company Secretary Jul 2020
Ms Erlyn Dale Joint Company Secretary Jul 2020
Mr Peter Ernest Hatfull Non-Executive Director Jul 2020 Director Bio icon

Mr Peter Ernest Hatfull

Non-Executive Director

Mr Hatfull has over 40 years' experience in a range of Board and senior executive positions with Australian and international companies. He has knowledge in the areas of business optimisation, capital raising and Group restructuring. Mr Hatfull is currently the independent Chairman of several listed and unlisted companies. Peter focusses in corporate governance and strategic planning and has held senior financial and board positions in Australia, Africa and the UK. Peter has worked for Coopers and Lybrand (now PriceWaterhouseCoopers), and subsequently moved to Africa, where he spent 8 years in Malawi prior to moving to Australia.

Dr James Anthony Ellingford Non-Executive Chairman,Non-Executive Director Jan 2020 Director Bio icon

Dr James Anthony Ellingford

Non-Executive Chairman,Non-Executive Director

Dr Ellingford previously served as International President of a NASDAQ software business Take-Two Interactive Software with its headquarters in Geneva and New York. He has international experience in the software industry and has close ties with financial institutions and governments throughout the world. He has knowledge in the areas of collaboration of media and digital assets, data sharing and corporate communications to enable workflow acceleration and has close ties with US based corporates who dominate this space. Dr Ellingford has lectured MBA students in Corporate Governance, ethics and marketing at a Sydney University.

Director Transactions

ESE directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
14/02/19 Benjamin Karasik Expiry 7,193,412 $0.026 $187,029 As advised by the company

Director Interests

The current holdings of ESE directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Peter Hatfull 02/07/2020 0 N/A N/A N/A
James Ellingford 13/01/2020 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Dec 31, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
N/A 0 0.00%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

No Substantial Shareholders for ESE in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2020 $0.019 30 June
2019 $0.017 28 June
2018 $0.072 29 June
2017 $0.285 28 June
Page Icon
ESE Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.